These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18207285)

  • 41. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
    Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
    Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: Indoline compounds as potent DPP-IV inhibitors.
    Sakashita H; Akahoshi F; Yoshida T; Kitajima H; Hayashi Y; Ishii S; Takashina Y; Tsutsumiuchi R; Ono S
    Bioorg Med Chem; 2007 Jan; 15(2):641-55. PubMed ID: 17113301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects.
    Dai H; Gustavson SM; Preston GM; Eskra JD; Calle R; Hirshberg B
    Diabetes Obes Metab; 2008 Jun; 10(6):506-13. PubMed ID: 18284437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization.
    Zeng S; Xie H; Zeng LL; Lu X; Zhao X; Zhang GC; Tu ZC; Xu HJ; Yang L; Zhang XQ; Hu W
    Bioorg Med Chem; 2013 Apr; 21(7):1749-55. PubMed ID: 23434133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of type 2 diabetes.
    Benbow JW; Andrews KA; Aubrecht J; Beebe D; Boyer D; Doran S; Homiski M; Hui Y; McPherson K; Parker JC; Treadway J; Vanvolkenberg M; Zembrowski WJ
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2220-3. PubMed ID: 19285862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site.
    Löster K; Zeilinger K; Schuppan D; Reutter W
    Biochem Biophys Res Commun; 1995 Dec; 217(1):341-8. PubMed ID: 8526932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization.
    Xie H; Zeng L; Zeng S; Lu X; Zhao X; Zhang G; Tu Z; Xu H; Yang L; Zhang X; Wang S; Hu W
    Eur J Med Chem; 2013 Oct; 68():312-20. PubMed ID: 23994324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).
    Paliwal S; Seth D; Yadav D; Yadav R; Paliwal S
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):129-40. PubMed ID: 21299434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham.
    Gallego M; Aristoy MC; Toldrá F
    Meat Sci; 2014 Feb; 96(2 Pt A):757-61. PubMed ID: 24200567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.
    Sutton JM; Clark DE; Dunsdon SJ; Fenton G; Fillmore A; Harris NV; Higgs C; Hurley CA; Krintel SL; MacKenzie RE; Duttaroy A; Gangl E; Maniara W; Sedrani R; Namoto K; Ostermann N; Gerhartz B; Sirockin F; Trappe J; Hassiepen U; Baeschlin DK
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1464-8. PubMed ID: 22177783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.
    Nordhoff S; Cerezo-Gálvez S; Deppe H; Hill O; López-Canet M; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4201-3. PubMed ID: 19515557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV.
    Kaelin DE; Smenton AL; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE; Duffy JL
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5806-11. PubMed ID: 17851076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors.
    Hu CX; Huang H; Zhang L; Huang Y; Shen ZF; Cheng KD; Du GH; Zhu P
    Biotechnol Lett; 2009 Jul; 31(7):979-84. PubMed ID: 19267232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
    Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H
    Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
    Liang GB; Qian X; Feng D; Biftu T; Eiermann G; He H; Leiting B; Lyons K; Petrov A; Sinha-Roy R; Zhang B; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1903-7. PubMed ID: 17291750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.
    Nishio Y; Kimura H; Tosaki S; Sugaru E; Sakai M; Horiguchi M; Masui Y; Ono M; Nakagawa T; Nakahira H
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7246-9. PubMed ID: 21074430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors.
    Ikuma Y; Hochigai H; Kimura H; Nunami N; Kobayashi T; Uchiyama K; Furuta Y; Sakai M; Horiguchi M; Masui Y; Okazaki K; Sato Y; Nakahira H
    Bioorg Med Chem; 2012 Oct; 20(19):5864-83. PubMed ID: 22938786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.
    Yoshida T; Sakashita H; Akahoshi F; Hayashi Y
    Bioorg Med Chem Lett; 2007 May; 17(9):2618-21. PubMed ID: 17317162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.